Credit Suisse’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,139,056
Closed -$91.3M 4291
2016
Q4
$91.3M Sell
1,139,056
-128,460
-10% -$10.2M 0.09% 225
2016
Q3
$101M Buy
1,267,516
+125,449
+11% +$10.1M 0.1% 207
2016
Q2
$89.1M Buy
1,142,067
+669,322
+142% +$47.7M 0.1% 203
2016
Q1
$26M Buy
472,745
+8,272
+2% +$451K 0.03% 606
2015
Q4
$28.7M Buy
464,473
+40,960
+10% +$2.58M 0.03% 608
2015
Q3
$26.7M Buy
423,513
+18,929
+5% +$1.35M 0.03% 595
2015
Q2
$29.6M Sell
404,584
-47,607
-11% -$3.44M 0.03% 630
2015
Q1
$29.6M Sell
452,191
-72,075
-14% -$4.79M 0.03% 641
2014
Q4
$34.1M Sell
524,266
-98,661
-16% -$6.35M 0.03% 630
2014
Q3
$37.5M Buy
622,927
+99,343
+19% +$6.49M 0.03% 629
2014
Q2
$36.3M Buy
523,584
+1,870
+0.4% +$121K 0.03% 635
2014
Q1
$34.1M Sell
521,714
-41,034
-7% -$2.67M 0.03% 587
2013
Q4
$34.9M Buy
562,748
+82,989
+17% +$4.81M 0.03% 557
2013
Q3
$25.7M Sell
479,759
-159,925
-25% -$8.24M 0.03% 613
2013
Q2
$29.2M Buy
+639,684
New +$27.7M 0.03% 578

Other funds holding STJ

Credit Suisse's STJ Position: Q1 2017 in Review

Credit Suisse sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,139,056 shares — an estimated $91.3M sold.

Credit Suisse first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $101M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Credit Suisse reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Credit Suisse sold 1,139,056 St Jude Medical shares in Q1 2017, an estimated $91.3M.
  • Credit Suisse first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Credit Suisse's St Jude Medical position peaked at $101M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.